Ocugen Inc

Research Ocugen Inc (OCGN) on Bullrun: market cap USD 565.33M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOCGN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 565.33M
• Financial periodFY2025
• RevenueUSD 4.41M
• Revenue growth8.8%
• Net income-USD 68.00M
• Free cash flow-USD 57.15M

Valuation Snapshot

latest market cap is USD 565.33M.

About Ocugen Inc

Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis;

Frequently asked questions

What is Ocugen Inc's market cap?

Ocugen Inc's market capitalization is USD 565.33M.

What does Ocugen Inc do?

Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that improve patients' health.